News Snapshot:
Vitamins maker Blackmores is vowing to look beyond the COVID-19 pandemic and seek growth in mental health and pet supplements as it offloads an acquisition made by former chief Christine Holgate in 2016. The $1.3 billion wellness business acknowledged at its annual general meeting on Tuesday the coronavirus pandemic had been a “huge challenge†for the company, but pointed to its continued strength in Australian and Asian markets and how its new Braeside facility had cemented its role as a local manufacturer. Alastair Symington is unwinding an acquisition made by former CEO Christine Holgate in 2016. Credit: Chief executive Alastair...
